Page last updated: 2024-08-17
thymidine and tram 34
thymidine has been researched along with tram 34 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barbaria, J; Beeton, C; Béraud, E; Bernard, D; Cahalan, MD; Chandy, KG; Clot-Faybesse, O; Pennington, M; Wulff, H | 1 |
Other Studies
1 other study(ies) available for thymidine and tram 34
| Article | Year |
|---|---|
Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Topics: Animals; Calcium Channel Blockers; CD4-Positive T-Lymphocytes; Cells, Cultured; Cnidarian Venoms; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Intermediate-Conductance Calcium-Activated Potassium Channels; Isotope Labeling; Kv1.3 Potassium Channel; Multiple Sclerosis; Phenotype; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyrazoles; Rats; Rats, Inbred Lew; Thymidine; Tritium | 2001 |